Cababat, Fernando .

HRN: 15-71-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/23/2026
03/02/2026
IV
1.5 Grams
Q8
Cellulitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: